aTyr Pharma | LIFE - Cost Of Sales

Stock Price
0.85
Daily Change
-0.02 -2.02%
Monthly
-13.53%
Yearly
-78.59%
Q1 Forecast
0.82

aTyr Pharma reported $22.13M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Ardelyx USD 3.98M 10.84M Sep/2025
aTyr Pharma USD 22.13M 6.75M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Cipla INR 29.1B 1.16B Dec/2025
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 1.65M 10K Sep/2025
CSL USD 3.87B 2.08B Dec/2025
Curis USD 10.27M 610K Jun/2024
Galapagos EUR 455K 84.28M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Grifols EUR 1.32B 22.75M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
United Therapeutics USD 474.7M 373.8M Dec/2025
Xoma 116K 112.7K Jun/2024